(Press-News.org) Patients with Parkinson disease who experienced pain before undergoing subthalamic nucleus deep brain stimulation (STN DBS) had that pain improved or eliminated at eight years after surgery, although the majority of patients developed new pain, mostly musculoskeletal, according to an article published online by JAMA Neurology.
Pain is a common nonmotor symptom in patients with Parkinson disease and it negatively impacts quality of life.
Beom S. Jeon, M.D., Ph.D., of the Seoul National University Hospital, Korea, and coauthors evaluated the long-term effect of STN DBS on pain in 24 patients with Parkinson disease who underwent STN DBS. Assessments of pain were conducted preoperatively and eight years after surgery.
Of the 24 patients, 16 (67 percent) experienced pain at baseline when not taking their medication and had an average pain score of 6.2, on a scale where 10 was maximal pain. All baseline pain improved or disappeared at eight years after surgery, according to the results. However, the authors discovered new pain developed in 18 of 24 patients (75 percent) during the eight-year follow-up. New pain impacted 47 body parts and the average pain score for new pain was 4.4. In most of the patients (11), new pain was musculoskeletal characterized by an aching and cramping sensation in joints or muscles, the authors note.
"We found that pain in PD [Parkinson disease] is improved by STN DBS and the beneficial effect persists after a long-term follow-up of eight years. In addition, new pain developed in most of the patients during the eight-year follow-up period. We also found that STN DBS is decidedly less effective for musculoskeletal pain and tends to increase over time. Therefore, musculoskeletal pain needs to be addressed independently," the study concludes.
(JAMA Neurol. Published online March 23, 2015. doi:10.1001/jamaneurol.2015.8. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Taking the Ouch Out of Parkinson Disease
In a related editorial, Richard B. Dewey, Jr., M.D., and Pravin Khemani, M.D., of the University of Texas Southwestern Medical Center, Dallas, write: "Because previous studies on pain following STN DBS for PD are of short duration, the durability of the procedure's effect on pain is not well established. The chief strength of the work by Jung and colleagues is the long follow-up period, which suggests that, although DBS may relieve pain for a time, this is not a durable effect owing to the onset of new, primarily musculoskeletal pain."
"Despite its limitations, the study by Jung and colleagues provides a novel perspective on the durability of the pain-relieving properties of STN DBS in PD. The authors direct our attention to the fact that musculoskeletal pain may emerge years after DBS, warranting individualized treatment," they continue.
"Although there is growing consensus that STN DBS decreases the level of pain in people with PD, the literature is mixed on the subtypes of pain that are responsive to DBS, and the study by Jung and colleagues shows that new pain arising years after the procedure is common. This underscores the importance of performing future trials with larger cohorts, longer observational periods and standard methods to enable effective interpretation of outcomes. For now, we have learned that STN DBS does not take the ouch out of PD in the long run," the editorial concludes.
(JAMA Neurol. Published online March 23, 2015. doi:10.1001/jamaneurol.2015.36. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: An author made conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
INFORMATION:
Media Advisory: To contact corresponding author Beom S. Jeon, M.D., Ph.D., email brain@snu.ac.kr To contact corresponding editorial author Richard B. Dewey, Jr., M.D., call Gregg Shields at 214-648-9354 or email gregg.shields@utsouthwestern.edu.
Fruit and vegetable selections in school meals increased after students had extended exposure to school food made more tasty with the help of a professional chef and after modifications were made to school cafeterias, including signage and more prominent placement of fruits and vegetables, but it was only chef-enhanced meals that also increased consumption, according to an article published online by JAMA Pediatrics.
More than 30 million students get school meals daily and many of them rely on school foods for up to half of their daily calories. Therefore, school-based ...
ROCHESTER, Minn - A Mayo Clinic study has identified a familial association in spontaneous coronary artery dissection, a type of heart attack that most commonly affects younger women, suggesting a genetic predisposition to the condition, researchers say. The results are published in the March 23 issue of JAMA Internal Medicine.
Researchers used the Mayo Clinic SCAD Registry of 412 enrollees to identify five familial cases of SCAD, comprised of three pairs of first-degree relatives (mother-daughter, identical twin sisters, sisters) and two pairs of second-degree relatives ...
AURORA, Colo. (March 23, 2015) - Discontinuing statin use in patients with late-stage cancer and other terminal illnesses may help improve patients' quality of life without causing other adverse health effects, according to a new study by led by researchers at the University of Colorado Anschutz Medical Campus and Duke University and funded by the National Institute of Nursing Research (NINR).
The finding, to be published in JAMA Internal Medicine on March 23, indicates that care for patients with advanced illness can be improved by discontinuing some therapies that are ...
DETROIT - Innovative angles of attack in research that focus on how the human brain protects and repairs itself will help develop treatments for one of the most common, costly, deadly and scientifically frustrating medical conditions worldwide: traumatic brain injury.
In an extensive opinion piece recently published online on Expert Opinion on Investigational Drugs, Henry Ford Hospital researcher Ye Xiong, M.D., Ph.D., makes the case for pioneering work underway in Detroit and elsewhere seeking to understand and repair brain function at the molecular level.
"To date, ...
A blood thinning agent is helping researchers at the University of East Anglia understand more about the body's natural barriers to HIV.
New research published today reveals how the protein langerin, which is present in genital mucous and acts as a natural HIV barrier during the first stages of contamination, interacts with the drug heparin.
The research team has been able to identify two different mechanisms for that interaction - involving different sites or 'faces' at the surface of the langerin protein.
Lead researcher Dr Jesus Angulo from UEA's school of Pharmacy ...
Lexington, MA (March 23, 2015) - Research results published in the Journal of Neurotrauma and conducted by the Walter Reed Army Institute of Research (WRAIR) as part of a collaboration with Concert Pharmaceuticals, Inc. showed that a novel deuterium-containing sigma-1 agonist invented at Concert, called C-10068, demonstrated anti-seizure and anti-inflammatory effects in a preclinical model of traumatic brain injury (TBI). C-10068, a novel metabolically-stabilized morphinan derivative, is based on a compound first identified at WRAIR in the 1990s as possessing anticonvulsant ...
Many smartphone users know that free apps sometimes share private information with third parties, but few, if any, are aware of how frequently this occurs. An experiment at Carnegie Mellon University shows that when people learn exactly how many times these apps share that information they rapidly act to limit further sharing.
In one phase of a study that evaluated the benefits of app permission managers - software that gives people control over what sensitive information their apps can access - 23 smartphone users received a daily message, or "privacy nudge," telling ...
March 23, 2015 - Patients with carpal tunnel syndrome are more than twice as likely to have migraine headaches, reports a study in Plastic and Reconstructive Surgery--Global Open®, the official open-access medical journal of the American Society of Plastic Surgeons (ASPS).
The association also runs in the other direction, with migraine patients having higher odds of carpal tunnel syndrome, according to research by Dr. Huay-Zong Law and colleagues of University of Texas Southwestern Medical Center at Dallas. The findings add a new piece of evidence in the ongoing debate ...
This news release is available in French. Raising the age of eligibility for the Old Age Security pension and the Guaranteed Income Supplement will increase inequalities between older people. "This change will force retired people into greater dependence on their private savings to support them as they get older. Research shows that greater privatisation of the retirement income system results in growing inequalities among the older population. When you raise the pension eligibility age, you are also opening the door to rising disparities" according to demographer Yves ...
Implementing a well-established business approach allowed physicians to shave hours off pediatric patient discharges without affecting readmission rates, according to researchers at Penn State Hershey Children's Hospital.
This approach could help hospitals around the country open up existing beds to more patients, and reduce emergency department crowding and lost referrals without investing significant capital.
Most hospitals have a fixed number of staffed beds available for patients. When hospitals are at or exceed capacity, admitted patients may be kept in the ED ...
